1859 companies

Newbury Pharmaceuticals

Market Cap: SEK 70.9m

Operates as hybrid pharmaceutical company in Sweden and the Scandinavian market.

NEWBRY

SEK 2.67

7D

2.7%

1Y

-14.4%

Exelixis

Market Cap: US$11.7b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

EXEL

US$42.39

7D

-6.6%

1Y

106.1%

Nanoform Finland Oyj

Market Cap: €83.8m

Engages in the provision of nanotechnology and drug particle engineering services for the pharma and biotech industries in Europe and the United States.

NANOFH

€0.98

7D

4.3%

1Y

-52.5%

Sopharma AD

Market Cap: лв1.1b

Produces, distributes, and exports pharmaceutical products in Europe, Bulgaria, and internationally.

SFA

лв6.54

7D

0.6%

1Y

6.5%

ImmunoPrecise Antibodies

Market Cap: US$22.4m

Operates as a techbio company.

IPA

US$0.56

7D

12.6%

1Y

-49.8%

MacroGenics

Market Cap: US$99.7m

A clinical-stage biopharmaceutical company, discovers, develops, manufactures, and commercializes antibody-based therapeutics to treat cancer in the United States.

MGNX

US$1.51

7D

-4.4%

1Y

-66.8%

Intellia Therapeutics

Market Cap: US$979.9m

A clinical-stage gene editing company, focuses on the development of curative genome editing treatments.

NTLA

US$9.16

7D

7.8%

1Y

-63.1%

Vicore Pharma Holding

Market Cap: SEK 1.9b

A clinical-stage pharmaceutical company, develops therapies for the treatment of respiratory diseases in Sweden.

VICO

SEK 8.15

7D

-4.6%

1Y

-54.0%

Monopar Therapeutics

Market Cap: US$216.6m

A clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States.

MNPR

US$35.45

7D

-4.6%

1Y

1,027.4%

Physiomics

Market Cap: UK£1.3m

Provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland.

PYC

UK£0.0042

7D

0%

1Y

-67.7%

LENZ Therapeutics

Market Cap: US$794.3m

Operates as a biopharmaceutical company that focuses on the development and commercialization of therapies to improve vision in the United States.

LENZ

US$28.18

7D

5.1%

1Y

79.5%

Vaxcyte

Market Cap: US$4.4b

A clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases.

PCVX

US$32.54

7D

2.2%

1Y

-52.7%

Barinthus Biotherapeutics

Market Cap: US$32.7m

A clinical-stage biopharmaceutical company, focuses on developing immunotherapeutic drug candidates for treating auto-immune and inflammatory diseases.

BRNS

US$0.65

7D

-30.7%

1Y

-70.4%

Inhalation Sciences Sweden

Market Cap: SEK 65.8m

Inhalation Sciences Sweden AB (publ) develops and sells labtech equipment for inhalation research.

ISAB

SEK 4.34

7D

0%

1Y

24.4%

Bayer (Peru)

Market Cap: S/294.5m

Engages in the pharmaceuticals, consumer health, and crop science businesses in Peru.

BAYERI1

S/20.00

7D

0%

1Y

41.8%

HBL - Hadasit Bio-Holdings

Market Cap: ₪4.5m

Operates in the biotechnology industry in Israel.

HDST-M

₪0.41

7D

0%

1Y

0%

Pharma-Bio Serv

Market Cap: US$9.9m

Operates as a regulatory affairs, compliance, and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally.

PBSV

US$0.43

7D

0%

1Y

-35.8%

Psyence Group

Market Cap: CA$1.4m

A life science biotechnology company, engages in the cultivation and production of commercial psilocybin mushroom.

PSYG

CA$0.15

7D

0%

1Y

-50.0%

G.F.C Green Fields Capital

Market Cap: ₪120.5m

Does not have significant operations.

GFC-M

₪12.00

7D

0.9%

1Y

n/a

JBM (Healthcare)

Market Cap: HK$2.1b

An investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally.

2161

HK$2.60

7D

22.6%

1Y

170.8%

Hanmi Pharm

Market Cap: ₩3.7t

A biopharmaceutical company, engages in the manufacture and sale of pharmaceutical products in South Korea, China, Japan, the United States, and internationally.

A128940

₩292,000.00

7D

-0.3%

1Y

-2.0%

Beta Drugs

Market Cap: ₹17.4b

Develops, manufactures, and sells anti-cancer drugs in India.

BETA

₹1,720.75

7D

-3.7%

1Y

49.4%

Immutep

Market Cap: AU$430.8m

A late-stage biotechnology company, engages in developing novel LAG-3 related immunotherapies for cancer and autoimmune diseases in Australia.

IMM

AU$0.29

7D

-3.3%

1Y

-33.7%

Zhejiang Jiuzhou Pharmaceutical

Market Cap: CN¥13.1b

Operates as contract development and manufacturing organization company in China and internationally.

603456

CN¥14.69

7D

3.2%

1Y

-3.5%

Jiangsu Sihuan Bioengineering

Market Cap: CN¥2.1b

Engages in the pharmaceutical business in China.

000518

CN¥2.08

7D

2.5%

1Y

-10.0%

BDH Industries

Market Cap: ₹1.5b

Engages in the manufacture and sale of therapeutic formulations covering a range of pharmaceuticals in India.

524828

₹262.60

7D

-3.1%

1Y

-27.9%

Binh Dinh Pharmaceutical and Medical Equipment

Market Cap: ₫4.8t

Manufactures and trades in pharmaceuticals and medical equipment in Vietnam.

DBD

₫51,500.00

7D

2.2%

1Y

22.6%

Quality Chemical Industries

Market Cap: USh317.7b

A pharmaceutical manufacturing company based in Uganda, produces treatments for HIV/AIDS, malaria, hepatitis, and other medical conditions.

QCIL

USh89.00

7D

2.3%

1Y

61.8%

China Traditional Chinese Medicine Holdings

Market Cap: HK$10.9b

China Traditional Chinese Medicine Holdings Co.

570

HK$2.17

7D

1.9%

1Y

-48.7%

CellSource

Market Cap: JP¥12.5b

Engages in the regenerative medicine-related businesses in Japan.

4880

JP¥629.00

7D

-3.4%

1Y

-52.7%

Guanhao BiotechLtd

Market Cap: CN¥3.6b

Develops, manufactures, and sells regenerative medicines and life sciences products primarily in China.

300238

CN¥13.50

7D

0.6%

1Y

30.7%

TMS

Market Cap: JP¥6.3b

Engages in the research and development, manufacture, and sale of drug products, quasi-drugs, drug substances, medical devices, and medical commodities.

4891

JP¥155.00

7D

6.9%

1Y

-32.0%

TaiwanJ Pharmaceuticals

Market Cap: NT$634.6m

A specialty pharmaceutical company, develops and commercializes small molecules for chronic organ inflammation of metabolic, autoimmune, and infectious etiologies in Taiwan.

6549

NT$7.92

7D

-0.9%

1Y

-32.9%

Oneness Biotech

Market Cap: NT$28.6b

Engages in the research, development, and sale of new drugs, pharmaceuticals, and health products primarily in Taiwan.

4743

NT$59.90

7D

-3.9%

1Y

-58.9%

High Tech Pharm

Market Cap: ₩133.9b

Researches and develops, manufactures, and sells injectable carbapenem-based antibiotics worldwide.

A106190

₩12,590.00

7D

8.0%

1Y

-21.8%

Sinil Pharmaceutical

Market Cap: ₩75.9b

Manufactures and sells pharmaceutical products in South Korea and internationally.

A012790

₩6,670.00

7D

4.4%

1Y

-5.4%

Page 5 of 52